A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy

BACKGROUND: The ideal prostate-specific antigen (PSA) doubling time (PSADT) threshold for identifying patients at high-risk for poor clinical outcome following salvage radiation therapy (SRT) has not been well established. We sought to assess what PSADT threshold is most clinically prognostic in thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, William C, Johnson, Skyler B, Li, Darren, Foster, Corey, Foster, Benjamin, Song, Yeohan, Schipper, Matthew, Shilkrut, Mark, Sandler, Howard M, Morgan, Todd M, Palapattu, Ganesh S, Hamstra, Daniel A, Feng, Felix Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718717/
https://www.ncbi.nlm.nih.gov/pubmed/23835115
http://dx.doi.org/10.1186/1748-717X-8-170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718717/
https://www.ncbi.nlm.nih.gov/pubmed/23835115
http://dx.doi.org/10.1186/1748-717X-8-170

Ejemplares similares